Tocagen, Inc. is a clinical-stage, cancer-selective gene therapy company, which engages in the development of product candidates designed to activate a patient's immune system against their own cancer. It is in the business of discovery, development, and commercialization of products for the treatment of cancer. The company was founded by Thomas E. Darcy, Harry E. Gruber, Douglas J. Jolly, and Dennis N. Berman in August 2007 and is headquartered San Diego, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
29
Frequently Asked Questions
What is Market Cap of Tocagen Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Tocagen Inc market cap is $23.62M.
What is the 52-week high for Tocagen Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Tocagen Inc 52 week high is $101.55 as of September 12, 2025.
What is the 52-week low for Tocagen Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Tocagen Inc 52 week low is $6.45 as of September 12, 2025.
What is Tocagen Inc stock price today?
Tocagen Inc stock price today is $14.75.
What was Tocagen Inc stock price yesterday?
Tocagen Inc stock price yesterday was $14.20.
What is the PE ratio of Tocagen Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Tocagen Inc’s P/E ratio is None.
What is the Price-to-Book ratio of Tocagen Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Tocagen Inc P/B ratio is 0.5109.
What is Tocagen Inc's EBITDA?
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Tocagen Inc's EBITDA is -0.46.
What is the 50-day moving average of Tocagen Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Tocagen Inc 50-day moving average is $18.33.